Regenerative Pain Medicine, the New Era of Interventional Pain Management, Restart Now!
Abstract
Musculoskeletal conditions become the leading contributor of the total years lived disability (YLD) by causing 21.3% of the YLDs, after mental and behavioral problems. Several musculoskeletal conditions give a disproportional impact on low back pain, one of the leading causes of disability. Lateral epicondylitis with a prevalence of 1-2%, commonly suffered by adults in their 30-65 years old. Epicondylitis was also suffered by a small population of athletes, such as professional tennis players (10% of epicondylitis population). The severe repetitive injuries that affect the individual daily activity also increase the daily health care cost.
Osteoarthritis and tendinopathy often become the cause of pain and musculoskeletal disability. However, the etiology of pain in osteoarthritis is multifactorial. The incidence of osteoarthritis reaches 6% in 30 years old population and increases due to aging.
Degenerative disease, the reduction of function or structure of the tissue or organ due to aging, encourages the pain specialist to perform a reliable pain management/therapy. Prolotherapy, especially dextrose prolotherapy, has become a promising technique by providing a safe degenerative therapy, easy to performed, and highly available in health facilities. Nowadays, it is necessary to pay more attention to causative-based treatment strategies than symptom-based treatment. A multidisciplinary team is also needed to provide appropriate treatment.
Full Text:
PDFReferences
Briggs AM, Cross MJ, Hoy DG, et al. Musculoskeletal Health Conditions Represent a Global Threat to Healthy Aging: A Report for the 2015 World Health Organization World Report on Ageing and Health. Gerontologist. 2016;56:S243-S255. doi:10.1093/geront/gnw002
Bhabra G, Wang A, Ebert JR, Edwards P, Zheng M, Zheng MH. Lateral Elbow Tendinopathy: Development of a Pathophysiology-Based Treatment Algorithm. Orthop J Sport Med. 2016;4(11):1-10. doi:10.1177/2325967116670635
De Smedt T, De Jong A, Van Leemput W, Lieven D, Van Glabbeek F. Lateral epicondylitis in tennis: Update on aetiology, biomechanics and treatment. Br J Sports Med. 2007;41(11):816-819. doi:10.1136/bjsm.2007.036723
Heogi,T. The Epidemioloy and Impact of Pain in Osteoarthritis. Osteoarthr Cartil. 2014;21(9):1145-1153. doi:10.1016/j.joca.2013.03.018.The
Zhang,Y. Epidemiology of osteoarthritis. Epidemiol Aging. 2012;26(3):523-536. doi:10.1007/978-94-007-5061-6_29
Rabago D, Nourani B. Prolotherapy for Osteoarthritis and Tendinopathy: a Descriptive Review. Curr Rheumatol Rep. 2017;19(6). doi:10.1007/s11926-017-0659-3
Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:139-159. doi:10.4137/CMAMD.S39160
Freeman JW, Empson YM, Ekwueme EC, Paynter DM, Brolinson PG. Effect of prolotherapy on cellular proliferation and collagen deposition in MC3T3-E1 and patellar tendon fibroblast populations. Transl Res. 2011;158(3):132-139. doi:10.1016/j.trsl.2011.02.008
Güran Ş, Dilşad çoban Z, Karasimav Ö, et al. Dextrose solution used for prolotherapy decreases cell viability and increases gene expressions of angiogenic and apopitotic factors. Gulhane Med J. 2018;60(2):42-46. doi:10.26657/gulhane.00016
Bayat M, Raeissadat SA, Babaki MM, Rahimi-Dehgolan S. Is dextrose prolotherapy superior to corticosteroid injection in patients with chronic lateral epicondylitis?: A randomized clinical trial. Orthop Res Rev. 2019;11:167-175. doi:10.2147/ORR.S218698
Guo S, DiPietro LA. Critical review in oral biology & medicine: Factors affecting wound healing. J Dent Res. 2010;89(3):219-229. doi:10.1177/0022034509359125
Koh KH. Corticosteroid injection for adhesive capsulitis in primarCorticosteroid primary care: A systematic review of randomised clinical trials. Singapore Med J. 2016;57(12):646-657. doi:10.11622/smedj.2016146
Bae G, Kim S, Lee S, Lee WY, Lim Y. Prolotherapy for the patients with chronic musculoskeletal pain: systematic review and meta-analysis. Anesth Pain Med. 2021;16(1):81-95. doi:10.17085/apm.20078
DOI: http://dx.doi.org/10.21776/ub.jap.2021.002.02.01
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.